Afuco™ Anti-AOC3 ADCC Therapeutic Antibody (Vapaliximab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to AOC3. Vapaliximab is a chimeric monoclonal antibody and an immunosuppressive drug.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-261 |
| Pricing | Inquiry |
| Host | Chimeric |
| Target | AOC3 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FC, IP, ELISA, Neut, FuncS |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |